These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 38669229)

  • 1. Characteristics of commercial determinants of health research on corporate activities: A scoping review.
    Burgess RC; Nyhan K; Dharia N; Freudenberg N; Ransome Y
    PLoS One; 2024; 19(4):e0300699. PubMed ID: 38669229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
    Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
    Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strategies to expand corporate autonomy by the tobacco, alcohol and sugar-sweetened beverage industry: a scoping review of reviews.
    Hoe C; Weiger C; Minosa MKR; Alonso F; Koon AD; Cohen JE
    Global Health; 2022 Feb; 18(1):17. PubMed ID: 35164801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The commercial determinants of Indigenous health and well-being: a systematic scoping review.
    Crocetti AC; Cubillo Larrakia B; Lock Ngiyampaa M; Walker Yorta Yorta T; Hill Torres Strait Islander K; Mitchell Mununjali F; Paradies Wakaya Y; Backholer K; Browne J
    BMJ Glob Health; 2022 Nov; 7(11):. PubMed ID: 36319033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. National Public Health Surveillance of Corporations in Key Unhealthy Commodity Industries - A Scoping Review and Framework Synthesis.
    Bennett E; Topp SM; Moodie AR
    Int J Health Policy Manag; 2023; 12():6876. PubMed ID: 37579395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Influence of Industry Sponsorship on the Research Agenda: A Scoping Review.
    Fabbri A; Lai A; Grundy Q; Bero LA
    Am J Public Health; 2018 Nov; 108(11):e9-e16. PubMed ID: 30252531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms for addressing and managing the influence of corporations on public health policy, research and practice: a scoping review.
    Mialon M; Vandevijvere S; Carriedo-Lutzenkirchen A; Bero L; Gomes F; Petticrew M; McKee M; Stuckler D; Sacks G
    BMJ Open; 2020 Jul; 10(7):e034082. PubMed ID: 32690498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conceptualizing the commercial determinants of dietary behaviors associated with obesity: A systematic review using principles from critical interpretative synthesis.
    Chavez-Ugalde Y; Jago R; Toumpakari Z; Egan M; Cummins S; White M; Hulls P; De Vocht F
    Obes Sci Pract; 2021 Aug; 7(4):473-486. PubMed ID: 34401205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conceptualising the Commercial Determinants of Health Using a Power Lens: A Review and Synthesis of Existing Frameworks.
    Wood B; Baker P; Sacks G
    Int J Health Policy Manag; 2022 Aug; 11(8):1251-1261. PubMed ID: 33619932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defining the commercial determinants of health: a systematic review.
    de Lacy-Vawdon C; Livingstone C
    BMC Public Health; 2020 Jun; 20(1):1022. PubMed ID: 32600398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Power and Other Commercial Determinants of Health: An Empirical Study of the Australian Food, Alcohol, and Gambling Industries.
    de Lacy-Vawdon C; Vandenberg B; Livingstone C
    Int J Health Policy Manag; 2023; 12():7723. PubMed ID: 37579379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Taking on the Corporate Determinants of Ill-health and Health Inequity: A Scoping Review of Actions to Address Excessive Corporate Power to Protect and Promote the Public's Health.
    Wood B; Lacy-Nichols J; Sacks G
    Int J Health Policy Manag; 2023; 12():7304. PubMed ID: 38618808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 'As Long as It Comes off as a Cigarette Ad, Not a Civil Rights Message': Gender, Inequality and the Commercial Determinants of Health.
    Hill SE; Friel S
    Int J Environ Res Public Health; 2020 Oct; 17(21):. PubMed ID: 33137876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Commercial determinants of health: an ethical exploration.
    Ndebele P; Shaikh H; Paichadze N; Bari I; Michaels D; Santos Burgoa C; Hyder AA
    Int J Public Health; 2020 Sep; 65(7):1123-1132. PubMed ID: 32840631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-communicable disease governance in the era of the sustainable development goals: a qualitative analysis of food industry framing in WHO consultations.
    Lauber K; Ralston R; Mialon M; Carriedo A; Gilmore AB
    Global Health; 2020 Aug; 16(1):76. PubMed ID: 32847604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Participation in environmental enhancement and conservation activities for health and well-being in adults: a review of quantitative and qualitative evidence.
    Husk K; Lovell R; Cooper C; Stahl-Timmins W; Garside R
    Cochrane Database Syst Rev; 2016 May; 2016(5):CD010351. PubMed ID: 27207731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Australia in 2030: what is our path to health for all?
    Backholer K; Baum F; Finlay SM; Friel S; Giles-Corti B; Jones A; Patrick R; Shill J; Townsend B; Armstrong F; Baker P; Bowen K; Browne J; Büsst C; Butt A; Canuto K; Canuto K; Capon A; Corben K; Daube M; Goldfeld S; Grenfell R; Gunn L; Harris P; Horton K; Keane L; Lacy-Nichols J; Lo SN; Lovett RW; Lowe M; Martin JE; Neal N; Peeters A; Pettman T; Thoms A; Thow AMT; Timperio A; Williams C; Wright A; Zapata-Diomedi B; Demaio S
    Med J Aust; 2021 May; 214 Suppl 8():S5-S40. PubMed ID: 33934362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Environmental, social, and governance (ESG) performance and financial outcomes: Analyzing the impact of ESG on financial performance.
    Chen S; Song Y; Gao P
    J Environ Manage; 2023 Nov; 345():118829. PubMed ID: 37688968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing the health impacts of transnational corporations: a case study of Carlton and United Breweries in Australia.
    Anaf J; Baum F; Fisher M; Haigh F; Miller E; Gesesew H; Freudenberg N
    Global Health; 2022 Sep; 18(1):80. PubMed ID: 36085238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.